
Directly located at the Lake of Ontario, Toronto is, in terms of population, the largest city in Canada. In addition to hosting the banking and stock exchange center of Canada, the city functions as the country’s primary wholesale and distribution point. Ontario’s wealth of raw materials and hydroelectric power have made Toronto a primary center of industry with Finance, Media, Technology and Tourism being the key industries. Due to the facts, many high net worth individuals settled down here: Thomson Family, Rogers Family and Carlo Fidani, just to name a few. Usually these individuals own their own private investment companies. In our we identified the largest single family offices in Canada, of which, we want to introduce you three of these investment companies that have their headquarters located in Toronto. The mentioned family offices are all part of our Rated 5.00 out of 5 €199,99 including VAT 30 entries, thereof 20 with general e-mail address, 26 with executive namesInvestment focus: Real Estate, Venture Capital, Private Equity, Financial Products, Renewables23 columns included: name, family name, estimated family wealth, detailed investment focus and exemplary investments, address, phone, e-mail, website…Free updates within one year included, secure payment through PayPal or Credit Card, 24/7 support through live chat and mail #1: Thomvest is the investment management firm of Peter J. Thomson, a Canadian rally race car driver and a venture capitalist with an estimated net worth over $6 billion, and his family. The company was established in 1996 and is split into three divisions: Thomvest Ventures, Thomvest Asset Management & Thomvest Properties. As you can guess, the firm focuses on real estate and venture capital investments but also completes private equity transactions through funds. The venture capital investments are typically made in the areas of financial technology, marketing technology, cybersecurity, sales, and cloud infrastructure sectors in early and growth stages. The mortgage company is an exemplary investment and provides people with a clear view of their finances and shows them where they may be losing money every month.#2: Dancap Family Investment Office serves as the private investment arm of the Dan Family and was founded in 2000. Aubrey Dan, a Canadian businessman, philanthropist and a producer, whose net worth is estimated to be around $1 billion, currently leads the firm. His father, Leslie Dan, founded the generic pharmaceutical manufacturer Novopharm. The Dancap Family Office invests in both alternative and traditional asset classes such as private equity, real estate, private debt, hedge funds, and public equities. Even though the Family Office is Canadian-based, its investment portfolio is global, with a primary focus on opportunities in the United States. For example, the company owns parts of the Heights at 2121 in Houston, a luxury apartment community. , as part of the private equity portfolio, is an innovation leader in the higher-end software market. Their team brings experience in deep integration with core systems, with integrations with student information systems, learning management systems, and authentication authorities. #3: Hedgewood, the private investment office of Jesse Rasch, was founded in 2000. Jesse Rasch is the co-founder and past Chairman & CEO of WebHosting.com and InQuent Technologies. Furthermore, he co-founded . InQuent provides private label hosting solutions to telecommunications customers. WebHosting.Com was one of the largest business web hosting companies in the world. In 2000, Rasch sold InQuent and WebHosting.Com to AT&T. As a globally minded investor, Hedgewood actively pursues and engages in a wide variety of investment opportunities in Canada, the United States, and internationally. The firm engages in venture capital, private equity, capital markets, lending and real estate. Real estate investments focus on retail, office, residential, farmland and timberland. Their venture capital focus lies on consumer & enterprise tech, health care and food/cpg. is an exemplary health care investment and pioneer in the application of commensal bacteria, with a transformative new platform technology and therapeutic and diagnostic approaches to the skin and the human microbiome.Picture source: These articles may also be interesting to you:Related
Lists: Rated 5.00 out of 5 €199,99 including VAT Rated 5.00 out of 5 Deal €2.499,98 Original price was: €2.499,98.€1.750,00Current price is: €1.750,00. including VAT Rated 5.00 out of 5 €399,99 including VAT Rated 5.00 out of 5 €799,99 including VAT
User Comments1. Grace
Campbell: Comment sample 1...2. M.
Phillips: Comment sample 2...3. S.
Wright: Comment sample 3...4. David
Jones: Comment sample 4...5. Emma Lee: Comment sample 5...Editor's NoteThis article was refined for clarity, structure, and user experience.

(Editors: admin)
Disclaimer & Copyright Notice:
This article is edited and compiled by the editorial team at WealthShield Asia based on publicly available information. It is intended for informational purposes only and does not constitute legal, financial, or investment advice.
We respect intellectual property rights. If you believe that any part of this article infringes upon your copyright or other legal rights, please contact us at
admin@wealthshield.asia. We will promptly review and remove the content if necessary.
All rights reserved. Unauthorized reproduction or redistribution is prohibited.